322 related articles for article (PubMed ID: 8678045)
1. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.
Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK
Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
[TBL] [Abstract][Full Text] [Related]
3. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
5. Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up.
Vohlonen I; Pukkala E; Malila N; Härkönen M; Hakama M; Koistinen V; Sipponen P
Scand J Gastroenterol; 2016 Oct; 51(10):1159-64. PubMed ID: 27338132
[TBL] [Abstract][Full Text] [Related]
6. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
9. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
11. High-Negative Anti-
Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.
Watanabe Y; Kurata JH; Mizuno S; Mukai M; Inokuchi H; Miki K; Ozasa K; Kawai K
Dig Dis Sci; 1997 Jul; 42(7):1383-7. PubMed ID: 9246033
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori and the development of atrophic gastritis].
Takahashi S; Igarashi H; Masubuchi N; Ishiyama N; Saito S; Aoyagi T; Itoh T; Hirata I
Nihon Rinsho; 1993 Dec; 51(12):3231-5. PubMed ID: 8283639
[TBL] [Abstract][Full Text] [Related]
14. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea.
Kim HY; Kim N; Kang JM; Park YS; Lee DH; Kim YR; Kim JS; Jung HC; Song IS
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):606-12. PubMed ID: 19293719
[TBL] [Abstract][Full Text] [Related]
15. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
[TBL] [Abstract][Full Text] [Related]
16. Is Helicobacter pylori a causal agent in gastric carcinoma?
Takahashi S; Igarashi H; Ishiyama N; Nakamura K; Masubuchi N; Ozaki M; Saito S; Aoyagi T; Itoh T; Hirata I
Zentralbl Bakteriol; 1993 Sep; 280(1-2):144-9. PubMed ID: 8280936
[TBL] [Abstract][Full Text] [Related]
17. Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.
Abnet CC; Zheng W; Ye W; Kamangar F; Ji BT; Persson C; Yang G; Li HL; Rothman N; Shu XO; Gao YT; Chow WH
Br J Cancer; 2011 Apr; 104(9):1511-6. PubMed ID: 21407214
[TBL] [Abstract][Full Text] [Related]
18. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study.
Muhsen K; Sinnreich R; Merom D; Nassar H; Cohen D; Kark JD
Hum Genomics; 2019 Jul; 13(1):32. PubMed ID: 31331390
[TBL] [Abstract][Full Text] [Related]
20. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
